136 related articles for article (PubMed ID: 20477813)
61. Positive prognostic impact of miR-210 in non-small cell lung cancer.
Eilertsen M; Andersen S; Al-Saad S; Richardsen E; Stenvold H; Hald SM; Al-Shibli K; Donnem T; Busund LT; Bremnes RM
Lung Cancer; 2014 Feb; 83(2):272-8. PubMed ID: 24305009
[TBL] [Abstract][Full Text] [Related]
62. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
[TBL] [Abstract][Full Text] [Related]
63. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
BMC Cancer; 2010 Apr; 10():172. PubMed ID: 20429924
[TBL] [Abstract][Full Text] [Related]
64. The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival.
Kilvaer TK; Paulsen EE; Khanehkenari MR; Al-Saad S; Johansen RM; Al-Shibli K; Bremnes RM; Busund LT; Donnem T
Br J Cancer; 2016 May; 114(10):1145-51. PubMed ID: 27167450
[TBL] [Abstract][Full Text] [Related]
65. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
[TBL] [Abstract][Full Text] [Related]
66. LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.
Hald SM; Rakaee M; Martinez I; Richardsen E; Al-Saad S; Paulsen EE; Blix ES; Kilvaer T; Andersen S; Busund LT; Bremnes RM; Donnem T
Clin Lung Cancer; 2018 May; 19(3):249-259.e2. PubMed ID: 29396238
[TBL] [Abstract][Full Text] [Related]
67. [Clinical significance of tumor interstitial T lymphocyte subset activity in non-small-cell lung cancer].
Xue L; Chen J; Peng JZ; Chen BS; Hua P; Yang YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2456-8. PubMed ID: 20034901
[TBL] [Abstract][Full Text] [Related]
68. CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.
Huang R; Wu D; Yuan Y; Li X; Holm R; Trope CG; Nesland JM; Suo Z
PLoS One; 2014; 9(11):e112209. PubMed ID: 25380303
[TBL] [Abstract][Full Text] [Related]
69. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
[TBL] [Abstract][Full Text] [Related]
70. Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.
Kubota D; Okubo T; Saito T; Suehara Y; Yoshida A; Kikuta K; Tsuda H; Katai H; Shimada Y; Kaneko K; Kawai A; Kondo T
Jpn J Clin Oncol; 2012 Aug; 42(8):730-41. PubMed ID: 22723667
[TBL] [Abstract][Full Text] [Related]
71. Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.
Kriegsmann M; Muley T; Harms A; Tavernar L; Goldmann T; Dienemann H; Herpel E; Warth A
Diagn Pathol; 2015 Dec; 10():210. PubMed ID: 26643918
[TBL] [Abstract][Full Text] [Related]
72. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
[TBL] [Abstract][Full Text] [Related]
73. Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma.
Banat GA; Tretyn A; Pullamsetti SS; Wilhelm J; Weigert A; Olesch C; Ebel K; Stiewe T; Grimminger F; Seeger W; Fink L; Savai R
PLoS One; 2015; 10(9):e0139073. PubMed ID: 26413839
[TBL] [Abstract][Full Text] [Related]
74. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
75. Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
Kilvaer TK; Rakaee M; Hellevik T; Østman A; Strell C; Bremnes RM; Busund LT; Dønnem T; Martinez-Zubiaurre I
PLoS One; 2018; 13(2):e0192157. PubMed ID: 29415055
[TBL] [Abstract][Full Text] [Related]
76. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236
[TBL] [Abstract][Full Text] [Related]
77. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
Bremnes RM; Al-Shibli K; Donnem T; Sirera R; Al-Saad S; Andersen S; Stenvold H; Camps C; Busund LT
J Thorac Oncol; 2011 Apr; 6(4):824-33. PubMed ID: 21173711
[TBL] [Abstract][Full Text] [Related]
78. Hemangioblastoma-like clear cell stromal tumor of the lung.
Falconieri G; Mirra M; Michal M; Suster S
Adv Anat Pathol; 2013 Mar; 20(2):130-5. PubMed ID: 23399799
[TBL] [Abstract][Full Text] [Related]
79. Clinical and Prognostic Significance of CD117 in Non-Small Cell Lung Cancer: A Systemic Meta-Analysis.
Su Y; Chen R; Han Z; Xu R; Ma L; Wufuli R; Liu H; Wang F; Ma L; Chen R; Liu J
Pathobiology; 2021; 88(4):267-276. PubMed ID: 34107476
[TBL] [Abstract][Full Text] [Related]
80. CD117 (c-KIT) overexpression in patients with extensive-stage small-cell lung carcinoma.
Potti A; Moazzam N; Ramar K; Hanekom DS; Kargas S; Koch M
Ann Oncol; 2003 Jun; 14(6):894-7. PubMed ID: 12796027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
